Risperidone versus other atypical antipsychotic medication for schizophrenia William T. Carpenter Jr Clinical Trials Report Pages: 375 - 375
Risperidone versus typical antipsychotic medication for schizophrenia William T. Carpenter Jr Clinical Trials Report Pages: 375 - 376
What risk factors tell us about the causes of schizophrenia and related psychoses Jane KellyRobin M. Murray OriginalPaper Pages: 378 - 385
Treating schizophrenia earlier in life and the potential for prevention Thomas H. McGlashan OriginalPaper Pages: 386 - 392
Evidence-based treatment of schizophrenia Robert E. DrakeKim T. MueserH. Steven Leff OriginalPaper Pages: 393 - 397
Should the treatment of schizophrenia include old antipsychotic drugs? Robby M. SteelEve C. Johnstone OriginalPaper Pages: 404 - 409
Update on childhood-onset schizophrenia Judith L. RapoportGale Inoff-Germain OriginalPaper Pages: 410 - 415
A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia Jeffrey L. Cummings Clinical Trials Report Pages: 419 - 419
Nortiptyline versus fluoxetine in the treatment of depression and in shortterm recovery after stroke: a placebo-controlled, double-blind study Jeffrey L. Cummings Clinical Trials Report Pages: 420 - 420
Depression in Alzheimer’s disease and other dementias Robert J. Boland OriginalPaper Pages: 427 - 433
